CHAPTER 1. Industry Overview of Bioanalytical Testing Services Market
1.1. Definition and Scope
1.1.1. Definition of Bioanalytical Testing Services
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Bioanalytical Testing Services Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Bioanalytical Testing Services Market By Molecule Type
1.2.3. Bioanalytical Testing Services Market By Test Type
1.2.4. Bioanalytical Testing Services Market By Workflow
1.2.5. Bioanalytical Testing Services Market By End-User
1.2.6. Bioanalytical Testing Services Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Bioanalytical Testing Services Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Bioanalytical Testing Services Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Bioanalytical Testing Services Market By Molecule Type
5.1. Introduction
5.2. Bioanalytical Testing Services Revenue By Molecule Type
5.2.1. Bioanalytical Testing Services Revenue (USD Billion) and Forecast, By Molecule Type, 2020-2032
5.2.2. Large Molecule
5.2.2.1. Large Molecule Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.2. Immunoassays
5.2.2.2.1. Immunoassays Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.3. LC-MS Studies
5.2.2.3.1. LC-MS Studies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.4. Others
5.2.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Small Molecule
5.2.3.1. Small Molecule Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Bioanalytical Testing Services Market By Test Type
6.1. Introduction
6.2. Bioanalytical Testing Services Revenue By Test Type
6.2.1. Bioanalytical Testing Services Revenue (USD Billion) and Forecast, By Test Type, 2020-2032
6.2.2. ADME
6.2.2.1. ADME Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.2.2. In-Vitro
6.2.2.2.1. In-Vitro Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.2.3. In- Vivo
6.2.2.3.1. In- Vivo Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. PD
6.2.3.1. PD Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. PK
6.2.4.1. PK Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.5. Bioequivalence
6.2.5.1. Bioequivalence Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.6. Bioavailability
6.2.6.1. Bioavailability Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.7. Others
6.2.7.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Bioanalytical Testing Services Market By Workflow
7.1. Introduction
7.2. Bioanalytical Testing Services Revenue By Workflow
7.2.1. Bioanalytical Testing Services Revenue (USD Billion) and Forecast, By Workflow, 2020-2032
7.2.2. Sample Analysis
7.2.2.1. Sample Analysis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Sample Preparation
7.2.3.1. Sample Preparation Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.4. Others
7.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. Bioanalytical Testing Services Market By End-User
8.1. Introduction
8.2. Bioanalytical Testing Services Revenue By End-User
8.2.1. Bioanalytical Testing Services Revenue (USD Billion) and Forecast, By End-User, 2020-2032
8.2.2. Pharmaceutical and Biotechnology Companies
8.2.2.1. Pharmaceutical and Biotechnology Companies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.3. Contract Development and Manufacturing Organization
8.2.3.1. Contract Development and Manufacturing Organization Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.4. Contract Research Organization
8.2.4.1. Contract Research Organization Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.5. Others
8.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 9. North America Bioanalytical Testing Services Market By Country
9.1. North America Bioanalytical Testing Services Market Overview
9.2. U.S.
9.2.1. U.S. Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Molecule Type, 2020-2032
9.2.2. U.S. Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Test Type, 2020-2032
9.2.3. U.S. Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Workflow, 2020-2032
9.2.4. U.S. Bioanalytical Testing Services Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.3. Canada
9.3.1. Canada Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Molecule Type, 2020-2032
9.3.2. Canada Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Test Type, 2020-2032
9.3.3. Canada Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Workflow, 2020-2032
9.3.4. Canada Bioanalytical Testing Services Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.4. North America PEST Analysis
CHAPTER 10. Europe Bioanalytical Testing Services Market By Country
10.1. Europe Bioanalytical Testing Services Market Overview
10.2. U.K.
10.2.1. U.K. Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Molecule Type, 2020-2032
10.2.2. U.K. Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Test Type, 2020-2032
10.2.3. U.K. Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Workflow, 2020-2032
10.2.4. U.K. Bioanalytical Testing Services Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.3. Germany
10.3.1. Germany Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Molecule Type, 2020-2032
10.3.2. Germany Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Test Type, 2020-2032
10.3.3. Germany Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Workflow, 2020-2032
10.3.4. Germany Bioanalytical Testing Services Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.4. France
10.4.1. France Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Molecule Type, 2020-2032
10.4.2. France Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Test Type, 2020-2032
10.4.3. France Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Workflow, 2020-2032
10.4.4. France Bioanalytical Testing Services Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.5. Spain
10.5.1. Spain Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Molecule Type, 2020-2032
10.5.2. Spain Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Test Type, 2020-2032
10.5.3. Spain Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Workflow, 2020-2032
10.5.4. Spain Bioanalytical Testing Services Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.6. Rest of Europe
10.6.1. Rest of Europe Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Molecule Type, 2020-2032
10.6.2. Rest of Europe Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Test Type, 2020-2032
10.6.3. Rest of Europe Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Workflow, 2020-2032
10.6.4. Rest of Europe Bioanalytical Testing Services Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Bioanalytical Testing Services Market By Country
11.1. Asia Pacific Bioanalytical Testing Services Market Overview
11.2. China
11.2.1. China Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Molecule Type, 2020-2032
11.2.2. China Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Test Type, 2020-2032
11.2.3. China Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Workflow, 2020-2032
11.2.4. China Bioanalytical Testing Services Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.3. Japan
11.3.1. Japan Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Molecule Type, 2020-2032
11.3.2. Japan Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Test Type, 2020-2032
11.3.3. Japan Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Workflow, 2020-2032
11.3.4. Japan Bioanalytical Testing Services Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.4. India
11.4.1. India Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Molecule Type, 2020-2032
11.4.2. India Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Test Type, 2020-2032
11.4.3. India Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Workflow, 2020-2032
11.4.4. India Bioanalytical Testing Services Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.5. Australia
11.5.1. Australia Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Molecule Type, 2020-2032
11.5.2. Australia Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Test Type, 2020-2032
11.5.3. Australia Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Workflow, 2020-2032
11.5.4. Australia Bioanalytical Testing Services Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.6. South Korea
11.6.1. South Korea Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Molecule Type, 2020-2032
11.6.2. South Korea Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Test Type, 2020-2032
11.6.3. South Korea Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Workflow, 2020-2032
11.6.4. South Korea Bioanalytical Testing Services Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Molecule Type, 2020-2032
11.7.2. Rest of Asia-Pacific Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Test Type, 2020-2032
11.7.3. Rest of Asia-Pacific Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Workflow, 2020-2032
11.7.4. Rest of Asia-Pacific Bioanalytical Testing Services Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Bioanalytical Testing Services Market By Country
12.1. Latin America Bioanalytical Testing Services Market Overview
12.2. Brazil
12.2.1. Brazil Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Molecule Type, 2020-2032
12.2.2. Brazil Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Test Type, 2020-2032
12.2.3. Brazil Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Workflow, 2020-2032
12.2.4. Brazil Bioanalytical Testing Services Revenue (USD Billion) and Forecast By End-User, 2020-2032
12.3. Mexico
12.3.1. Mexico Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Molecule Type, 2020-2032
12.3.2. Mexico Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Test Type, 2020-2032
12.3.3. Mexico Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Workflow, 2020-2032
12.3.4. Mexico Bioanalytical Testing Services Revenue (USD Billion) and Forecast By End-User, 2020-2032
12.4. Rest of Latin America
12.4.1. Rest of Latin America Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Molecule Type, 2020-2032
12.4.2. Rest of Latin America Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Test Type, 2020-2032
12.4.3. Rest of Latin America Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Workflow, 2020-2032
12.4.4. Rest of Latin America Bioanalytical Testing Services Revenue (USD Billion) and Forecast By End-User, 2020-2032
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Bioanalytical Testing Services Market By Country
13.1. Middle East & Africa Bioanalytical Testing Services Market Overview
13.2. GCC
13.2.1. GCC Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Molecule Type, 2020-2032
13.2.2. GCC Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Test Type, 2020-2032
13.2.3. GCC Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Workflow, 2020-2032
13.2.4. GCC Bioanalytical Testing Services Revenue (USD Billion) and Forecast By End-User, 2020-2032
13.3. South Africa
13.3.1. South Africa Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Molecule Type, 2020-2032
13.3.2. South Africa Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Test Type, 2020-2032
13.3.3. South Africa Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Workflow, 2020-2032
13.3.4. South Africa Bioanalytical Testing Services Revenue (USD Billion) and Forecast By End-User, 2020-2032
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Molecule Type, 2020-2032
13.4.2. Rest of Middle East & Africa Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Test Type, 2020-2032
13.4.3. Rest of Middle East & Africa Bioanalytical Testing Services Revenue (USD Billion) and Forecast By Workflow, 2020-2032
13.4.4. Rest of Middle East & Africa Bioanalytical Testing Services Revenue (USD Billion) and Forecast By End-User, 2020-2032
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Bioanalytical Testing Services Market
14.1. Bioanalytical Testing Services Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global Bioanalytical Testing Services Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. PSC
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Billion), 2022
15.1.3.2. PSC 2022 Bioanalytical Testing Services Business Regional Distribution
15.1.4. Product /Service and Specification
15.1.5. Recent Developments & Business Strategy
15.2. SGS SA
15.3. Toxikon, Inc.
15.4. The Intertech group
15.5. Pace Analytical Services
15.6. SLC
15.7. PPD
15.8. ICON plc
15.9. Covance Inc.
15.10. LabCorp
15.11. Charles River Laboratories International, Inc.
15.12. Syneos Health
15.13. Toxikon
15.14. IQVIA
The market size of bioanalytical testing services was USD 4.2 billion in 2022.
The CAGR of bioanalytical testing services is 10.7% during the analysis period of 2023 to 2032.
The key players operating in the global market are including PSC, SGS SA, Toxikon, Inc., The Intertech group, Pace Analytical Services, SLC, PPD, ICON plc, Covance Inc., LabCorp, Charles River Laboratories International, Inc., Syneos Health, Toxikon, and IQVIA.
North America held the dominating position in bioanalytical testing services industry during the analysis period of 2023 to 2032.
Asia-Pacific region exhibited fastest growing CAGR for market of bioanalytical testing services during the analysis period of 2023 to 2032.
The current trends and dynamics in the bioanalytical testing services industry include increasing demand for personalized medicine and targeted therapies, growth in pharmaceutical R&D activities and drug development, stringent regulatory requirements driving the need for accurate testing, and advancements in technology enhancing analytical capabilities in testing methodologies.
The small molecule molecule type held the maximum share of the bioanalytical testing services industry.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date